CAPRICOR THERAPEUTICS, INC. Business Finance Contracts & Agreements
58 Contracts & Agreements
- Funding Agreements (1 contract)
- Loan Agreements (12)
- Note Agreements (3)
- Purchase Agreements (5)
- Registration Rights Agreements (4)
- Security Agreements (1)
- Share Agreements (3)
- Stock Agreements (14)
- Subscription Agreements (4)
- Underwriting Agreements (1)
- Warrant Agreements (10)
- Form of Securities Purchase Agreement (Filed With SEC on September 29, 2023)
- Form of Warrant (Filed With SEC on September 29, 2023)
- Description of the Companys Common Stock, par value $0.001 per share (Filed With SEC on March 17, 2023)
- Description of the Companys Common Stock, par value $0.001 per share (Filed With SEC on March 11, 2022)
- Description of the Companys Common Stock, par value $0.001 per share (Filed With SEC on March 15, 2021)
- Form of Common Stock Purchase Warrant, issued by the Company to certain employees of the placement agent on March 27, 2020 (Filed With SEC on May 15, 2020)
- Form of Common Stock Purchase Warrant, issued by the Company to the Exercising Holder on March 25, 2020 (Filed With SEC on May 15, 2020)
- Description of the Companys Common Stock, par value $0.001 per share (Filed With SEC on March 27, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on December 18, 2019)
- Form of Placement Agent Warrant (Filed With SEC on December 13, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on December 13, 2019)
- Form of Common Warrant (Filed With SEC on December 13, 2019)
- Form of Securities Purchase Agreement (Filed With SEC on December 13, 2019)
- Common Stock Sales Agreement, dated July 22, 2019, between Capricor Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on July 22, 2019)
- Amendment No. 3 to the CIRM Notice of Loan Award, dated December 11, 2017 (Filed With SEC on December 12, 2017)
- Common Stock Sales Agreement, dated October 19, 2017, between Capricor Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on October 19, 2017)
- AMENDMENTTO NOTICE OF LOAN AWARD – RFA 10-05A - CIRM Disease Team Therapy Development Awards - Part II Research Award CaliforniaInstitute for Regenerative Medicine (Filed With SEC on June 13, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on May 9, 2017)
- SUBSCRIPTION AGREEMENT (Filed With SEC on May 9, 2017)
- CAPRICORTHERAPEUTICS, INC. $5,000,000 cOMMON STOCK SALES AGREEMENT (Filed With SEC on March 31, 2017)
- SUBSCRIPTION AGREEMENT (Filed With SEC on September 16, 2016)
- 2,687,500 Shares CAPRICOR THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on September 16, 2016)
- Loan Election Agreement Between the California Institute for RegenerativeMedicine and Capricor, Inc. (Filed With SEC on August 15, 2016)
- AMENDMENT TO NOTICE OF LOAN AWARD –RFA 10-05A - CIRM Disease Team Therapy Development Awards - Part II Research Award California Institute for Regenerative Medicine (Filed With SEC on August 15, 2016)
- SUBSCRIPTION AGREEMENT (Filed With SEC on March 16, 2016)
- CAPRICOR THERAPEUTICS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on March 16, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 16, 2016)
- AMENDMENT TO SHARE PURCHASE AGREEMENT (Filed With SEC on February 6, 2015)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 6, 2015)
- SHARE PURCHASE AGREEMENT (Filed With SEC on February 6, 2015)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 22, 2015)
- SHARE PURCHASE AGREEMENT (Filed With SEC on January 22, 2015)
- SIGN AND RETURN THIS PAGE TOCIRM DR2A-05735 NOTICE OF LOAN AWARD – CIRM RFA10-05: Disease Team Therapy Development Research Awards California Institute for RegenerativeMedicine (Filed With SEC on March 31, 2014)
- CALIFORNIA INSTITUTE FOR REGENERATIVEMEDICINE LOAN AGREEMENT (Filed With SEC on March 31, 2014)
- [FORM OF] FIRST AMENDMENT TO NILE THERAPEUTICS, INC. SECURED CONVERTIBLE PROMISSORY NOTES (Filed With SEC on October 3, 2013)
- SECURITY AGREEMENT (Filed With SEC on March 22, 2013)
- CONVERTIBLE NOTE PURCHASE AGREEMENT (Filed With SEC on March 22, 2013)
- NILE THERAPEUTICS, INC. SECUREDCONVERTIBLE PROMISSORY NOTE (Filed With SEC on March 22, 2013)
- NILETHERAPEUTICS, INC. WarrantTo Purchase Common Stock (Filed With SEC on April 2, 2012)
- NILE THERAPEUTICS, INC. 3,350,000 shares of Common Stock and Warrants to purchase up to 2,512,500shares of Common Stock PLACEMENT AGENT AGREEMENT (Filed With SEC on April 2, 2012)
